These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22802275)

  • 1. Transient osteoporosis associated with pregnancy: use of bisphosphonate in treating a lactating mother.
    Shenker NG; Shaikh MF; Jawad AS
    BMJ Case Rep; 2010 Dec; 2010():. PubMed ID: 22802275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health.
    Mastaglia SR; Watman NP; Oliveri B
    Osteoporos Int; 2010 Nov; 21(11):1959-62. PubMed ID: 20535608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis.
    Li LJ; Zhang J; Gao P; Lv F; Song YW; Chang XY; Zhao DC; Wang O; Jiang Y; Xing XP; Xia WB; Li M
    Clin Rheumatol; 2018 Nov; 37(11):3141-3150. PubMed ID: 29946989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of regional migratory osteoporosis.
    Spierings J; Bours S; Peeters HRM
    Osteoporos Int; 2018 Feb; 29(2):507-510. PubMed ID: 29064043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of i. v. bisphosphonate in pregnancy-associated osteoporosis--case study.
    Hellmeyer L; Kühnert M; Ziller V; Schmidt S; Hadji P
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):139-42. PubMed ID: 17318776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy and Lactation-Associated Osteoporosis: Bone Histomorphometric Analysis and Response to Treatment with Zoledronic Acid.
    Grizzo FM; da Silva Martins J; Pinheiro MM; Jorgetti V; Carvalho MD; Pelloso SM
    Calcif Tissue Int; 2015 Oct; 97(4):421-5. PubMed ID: 26108650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient migratory osteoporosis: rapid response to pamidronate treatment.
    Carty S; Herdman G; Williams F; Srinivasan U
    J Clin Rheumatol; 2007 Jun; 13(3):138-9. PubMed ID: 17551379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome.
    Vujasinovic-Stupar N; Pejnovic N; Markovic L; Zlatanovic M
    Rheumatol Int; 2012 Mar; 32(3):819-23. PubMed ID: 21327429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncommon transient osteoporosis of pregnancy at multiple sites associated with cytomegalovirus infection: is there a link?
    Rozenbaum M; Boulman N; Rimar D; Kaly L; Rosner I; Slobodin G
    Isr Med Assoc J; 2011 Nov; 13(11):709-11. PubMed ID: 22279710
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiological findings in cyclical administration of intravenous pamidronate in children with osteoporosis.
    Onwuneme C; Abdalla K; Cassidy N; Hensey O; Ryan S
    Arch Dis Child; 2007 Dec; 92(12):1087. PubMed ID: 18032639
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of intravenous pamidronate to standard therapy for osteoporosis: use in patients unable to take oral bisphosphonates.
    Miller RG; Chretien KC; Meoni LA; Liu YP; Klag MJ; Levine MA
    J Clin Rheumatol; 2005 Feb; 11(1):2-7. PubMed ID: 16357689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and treatment costs of zoledronate versus pamidronate in paediatric osteoporosis.
    Saraff V; Sahota J; Crabtree N; Sakka S; Shaw NJ; Högler W
    Arch Dis Child; 2018 Jan; 103(1):92-94. PubMed ID: 28988216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates in pregnancy and lactation-associated osteoporosis.
    O'Sullivan SM; Grey AB; Singh R; Reid IR
    Osteoporos Int; 2006; 17(7):1008-12. PubMed ID: 16758139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of pregnancy and lactation-associated osteoporosis: analysis of 4 cases].
    He XD; Xia WB; Xing XP; Li M; Jiang Y; Wang O; Xu LL; Xu JP
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(14):983-5. PubMed ID: 19671313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintigraphic findings of growth arrest lines after bisphosphonate administration in a steroid-induced osteoporosis patient: a case study.
    Hong IK; Suh JS; Lee YA; Kim DY
    Clin Nucl Med; 2010 Sep; 35(9):740-2. PubMed ID: 20706059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review.
    Nasomyont N; Hornung LN; Gordon CM; Wasserman H
    Bone; 2019 Apr; 121():60-67. PubMed ID: 30616029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.
    Barros ER; Dias da Silva MR; Kunii IS; Lazaretti-Castro M
    J Pediatr Endocrinol Metab; 2008 Aug; 21(8):811-8. PubMed ID: 18825883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intravenous pamidronate versus oral alendronate on bone mineral density in patients with osteoporosis.
    Vis M; Bultink IE; Dijkmans BA; Lems WF
    Osteoporos Int; 2005 Nov; 16(11):1432-5. PubMed ID: 15883662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torg-Winchester syndrome: lack of efficacy of pamidronate therapy.
    Phadke SR; Ramirez M; DiFeo A; Martignetti JA; Girisha KM
    Clin Dysmorphol; 2007 Apr; 16(2):95-100. PubMed ID: 17351352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.